OXFORD BIODYNAMICS PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.278 GBX | +3.61% |
|
+10.14% | -69.36% |
| 11:30am | Oxford BioDynamics develops canine cancer test with 89% accuracy | AN |
| 08:00am | OBD Develops Multi-Cancer Diagnostic Test for Dogs | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OXFORD BIODYNAMICS PLC | Other Biotechnology & Medical Research | +3.61% | +10.14% | -69.36% | -37.37% | -93.67% | 20.67M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- OBD Stock
- Charts Oxford BioDynamics Plc
- Comparison Chart